Kód: 01431557
Myelodysplastic Syndrome (MDS): How common is it? i.e. epidemiology and risk factors.- Therapy related myelodysplasia. Predisposing factors and molecular genetics.- Cytogenetic abnormalities in primary and secondary MDS.- The valu ... celý popis
6141 Kč
Dostupnost:
50 % šanceMáme informaci, že by titul mohl být dostupný. Na základě vaší objednávky se ho pokusíme do 6 týdnů zajistit.Zadejte do formuláře e-mailovou adresu a jakmile knihu naskladníme, zašleme vám o tom zprávu. Pohlídáme vše za vás.
Nákupem získáte 614 bodů
Myelodysplastic Syndrome (MDS): How common is it? i.e. epidemiology and risk factors.- Therapy related myelodysplasia. Predisposing factors and molecular genetics.- Cytogenetic abnormalities in primary and secondary MDS.- The value of SNP and expression profiling in diagnosis and prognosis.- Molecular pathology of 5q-syndrome and 5q- abnormality.- Genomic instability syndromes and myelodysplasia.- Animal models of myelodysplasia.- Biological defects of haemopoiesis of low risk MDS.- Prognostic evaulation of primary MDS.- FAB, WHO, IWG and beyond.- Methylation and histone acetylation in the context of MDS.- Treatment of MDS with demethylating agents and HDAC inhibitor.- Supportive treatment in low and high risk MDS.- Allogeneic stem cell transplantation in MDS.- Immune dysregulation and immunosuppressive therapy MDS.- Aplastic anaemia/MDS overlap syndrome.- Clinical and molecular spectrum of Myeloproliferative/Myelodysplastic disorders (MPD/MDS).- MPD/MDS overlap syndromes.- Adult and juvenile Chronic Myelomonocytic Leukemia (CMML.- Emerging therapies including Lenolidamide
6141 Kč
Osobní odběr Praha, Brno a 12903 dalších
Copyright ©2008-24 nejlevnejsi-knihy.cz Všechna práva vyhrazenaSoukromíCookies
Nákupní košík ( prázdný )
Nacházíte se: